Monitoring of long-term effects of resveratrol on cell cycle progression of human hela cells after administration of a single dose

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 257-263

  Kramer, Matthias P ^a   Wȩsierska Ga̧dek, Józefa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell cycle; Cell cycle re entry; Roscovitine; S phase synchronization; Synergistic effect

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; RESVERATROL; ROSCOVITINE;

CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENTIATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MITOSIS INHIBITION; TREATMENT DURATION; UTERINE CERVIX CARCINOMA;

HUMAN PAPILLOMAVIRUS;

EID: 69149091195     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04884.x     Document Type: Conference Paper

References (24)

1. Sun, A.Y., A. Simonyi G.Y. Sun. 2002. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol. Med. 32 : 314 318.
2. Jang, M. et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 : 218 220.
3. Alkhalaf, M. et al. 2008. Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Arch. Med. Res. 39 : 162 168.
4. Byun, H.S. et al. 2008. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47 : 301 308.
5. Pozo-Guisado, E. et al. 2005. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int. J. Cancer 115 : 74 84.
6. Hu, Y. et al. 2007. Antimyeloma effects of resveratrol through inhibition of angiogenesis. Chin. Med. J. (Engl.) 120 : 1672 1677.
7. Jazirehi, A.R. B. Bonavida. 2004. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol. Cancer Ther. 3 : 71 84.
8. Zoberi, I. et al. 2002. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett. 175 : 165 173.
9. Ahmad, N. et al. 2001. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7 : 1466 1473.
10. Kotha, A. et al. 2006. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol. Cancer Ther. 5 : 621 629.
11. Tyagi, A. et al. 2005. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26 : 1978 1987.
12. Park, J.W. et al. 2001. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett. 163 : 43 49.
13. Wesierska-Gadek, J., M.P. Kramer M. Maurer. 2008. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. Food Chem. Toxicol. 46 : 1327 1333.
14. Liang, Y.C. et al. 2003. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 65 : 1053 1060.
15. McClue, S.J. et al. 2002. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int. J. Cancer 102 : 463 468.
16. Wesierska-Gadek, J. G. Schmid. 2000. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint. J. Cell Biochem. 80 : 85 103.
17. Vindelov, L.L., I.J. Christensen N.I. Nissen. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3 : 323 327.
18. Juan, M.E., M.P. Vinardell J.M. Planas. 2002. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132 : 257 260.
19. Ahmad, A., S. Farhan Asad, S. Singh S.M. Hadi. 2000. DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation. Cancer Lett. 154 : 29 37.
20. Burkitt, M.J. J. Duncan. 2000. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. Arch. Biochem. Biophys. 381 : 253 263.
21. Fukuhara, K., M. Nagakawa, I. Nakanishi, et al. 2006. Structural basis for DNA-cleaving activity of resveratrol in the presence of Cu(II). Bioorg. Med. Chem. 14 : 1437 1443.
22. Subramanian, M., U. Shadakshari S. Chattopadhyay. 2004. A mechanistic study on the nuclease activities of some hydroxystilbenes. Bioorg. Med. Chem. 12 : 1231 1237.
23. Win, W., Z. Cao, X. Peng, et al. 2002. Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513 : 113 120.
24. Gatz, S.A., M. Keimling, C. Baumann, et al. 2008. Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner. Carcinogenesis 2008 Jan 3; [Epub ahead of print].